Document is current
Any future updates will be listed below
-
Authors
Chen, Wei-Heng
Lai, Wei-Yu
Le, Duy-Cuong https://orcid.org/0009-0000-9503-0306
Hsing, Jui-Chien
Ngo, Mai-Huong T.
Kao, Cheng-Xiang
Fan, Kang-Yun
Lin, Gee-Way
Ling, Thai-Yen
Kuo, Yung-Che
Huang, Yen-Hua https://orcid.org/0000-0001-6020-9998
-
Funding
Funding for this research was provided by:
National Science and Technology Council (MOST 110-2314-B-038-132)
National Science and Technology Council (NSTC 111-2314-B-038-089-MY3)
National Science and Technology Council (NSTC 111-2314-B-038-018)
National Science and Technology Council (NSTC 112-2314-B-038-007)
National Science and Technology Council (NSTC 113-2314-B-038-136)
National Science and Technology Council (MOST 111-2320-B-038-022)
National Science and Technology Council (NSTC 112-2320-B-038-011-MY3)
National Science and Technology Council (NSTC 114-2314-B-038-081)
National Science and Technology Council (NSTC 114-2314-B-038-012)
- License Information
-
More Information
Article History
Received: 28 April 2025
Accepted: 18 September 2025
First Online: 14 October 2025
Declarations
:
: All animal experiment protocols were approved by the Institutional Animal Care and Use Committee of Taipei Medical University, Taiwan. Experiments were conducted following the instructions outlined in the Guide for the Care and Use of Laboratory Animals. (Title of the approved project: To investigate the role of clinical placental mesenchymal stem cell secretome in promoting the proliferation and immunomodulation of meniscus progenitor cells; Approval No. LAC2022-0271; Date of approval: Dec 09, 2022). The human pcMSC-derived secretome was original sourced from Professor Thai-Yen Ling’s laboratory (National Taiwan University, Taiwan). We have confirmed that the collection of human cells received initial ethical approval, and all donors have signed informed consent forms.
: Not applicable.
: The authors have no competing interests to declare.
